Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 6:45 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 193–216 of 4,558 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: obesity Clear all

Conditions: Obesity, Physical Activity, Exercise
Interventions: Exercise instruction with motivational interview, Self-monitoring; Behavioral
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years to 59 Years
Enrollment: 19 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Scottsdale, Arizona

Conditions: Obesity, Overweight
Interventions: Whey Protein, Whey Protein and Resistance Exericse, Whey Protein and RISE exercise routine; Dietary Supplement · Other
Lead sponsor: Skidmore College; Other
Eligibility: 30 Years to 60 Years
Enrollment: 79 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2012
U.S. locations: 1
States / cities: Saratoga Springs, New York

Conditions: Polycystic Ovary Syndrome
Interventions: Nutropin; Drug
Lead sponsor: Oregon Health and Science University; Other
Eligibility: 21 Years to 45 Years · Female only
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2011
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Diabetes Mellitus Type 2, Non Alcoholic Fatty Liver Disease, Obesity
Interventions: Amlexanox; Drug
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years to 75 Years
Enrollment: 7 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Cognition, Obese Older Adults, Mediterranean Diet
Interventions: MedDiet; Behavioral
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 55 Years to 85 Years
Enrollment: 180 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2021
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Obesity
Interventions: TransPyloric Shuttle, Sham procedure, Lifestyle Counseling; Device · Behavioral
Lead sponsor: BaroNova, Inc.; Industry
Eligibility: 22 Years to 60 Years
Enrollment: 302 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2018
U.S. locations: 9
States / cities: Scottsdale, Arizona • San Diego, California • Miami, Florida + 6 more

Conditions: High Intensity Interval Training, Overweight and Obesity, Metabolic Disease, Cognition
Interventions: HIIT Exercise Intervention, Stretching Intervention; Behavioral
Lead sponsor: University of Southern California; Other
Eligibility: 12 Years to 16 Years
Enrollment: 6 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Type 2 Diabetes Mellitus
Interventions: Lixisenatide (AVE0010), Lixisenatide Placebo, Pen auto-injector, Sitagliptin, Sitagliptin Placebo, Metformin; Drug · Device
Lead sponsor: Sanofi; Industry
Eligibility: 18 Years to 49 Years
Enrollment: 319 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2011
U.S. locations: 21
States / cities: Montgomery, Alabama • Muscle Shoals, Alabama • Mesa, Arizona + 17 more

Conditions: Health Status Disparities, Pediatric Obesity, Ethnic Group, Socioeconomic Factors
Interventions: After school program, Summer day camp; Behavioral
Lead sponsor: University of South Carolina; Other
Eligibility: 5 Years to 12 Years
Enrollment: 480 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2028
U.S. locations: 1
States / cities: Columbia, South Carolina

Conditions: Infertility, Female
Interventions: Caloric Restriction, Orlistat, Moderate physical activity; Other · Drug
Lead sponsor: Yale University; Other
Eligibility: 18 Years to 40 Years · Female only
Enrollment: 379 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2020
U.S. locations: 10
States / cities: San Francisco, California • Augusta, Georgia • Southfield, Michigan + 7 more

Conditions: Overweight and Obesity
Interventions: SMART device; Device
Lead sponsor: Scientific Intake Limited Co.; Industry
Eligibility: 18 Years to 49 Years
Enrollment: 76 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2015
U.S. locations: 4
States / cities: San Diego, California • Waterbury, Connecticut • Coral Gables, Florida + 1 more

Conditions: Obesity, Type 2 Diabetes, Metabolic Syndrome
Interventions: Not listed
Lead sponsor: Joslin Diabetes Center; Other
Eligibility: 18 Years to 80 Years
Enrollment: 110 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2017
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Obesity, Obesity, Morbid, Pregnancy, Infection; Cesarean Section
Interventions: Cefazolin; Drug
Lead sponsor: MemorialCare Health System; Other
Eligibility: Female only
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 2
States / cities: Long Beach, California • Orange, California

Conditions: Gastric Bypass Status
Interventions: rivaroxaban; Drug
Lead sponsor: State University of New York - Upstate Medical University; Other
Eligibility: 18 Years and older
Enrollment: 2 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2015
U.S. locations: 1
States / cities: Syracuse, New York

Conditions: Morbid Obesity
Interventions: Plication; Procedure
Lead sponsor: Ohio State University; Other
Eligibility: 18 Years to 70 Years
Enrollment: 17 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2016
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Acute Lymphoblastic Leukemia, Obesity
Interventions: PEDALL, Standard of care; Behavioral · Other
Lead sponsor: Columbia University; Other
Eligibility: 5 Years to 21 Years
Enrollment: 376 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: New York, New York

Conditions: Obesity
Interventions: Deep Brain Stimulation Device; Device
Lead sponsor: Ali Rezai, MD; Other
Eligibility: 22 Years to 60 Years
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2016
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Overweight or Obesity
Interventions: AMG 133, Placebo, Acetaminophen; Drug
Lead sponsor: Amgen; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 57 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025
U.S. locations: 1
States / cities: Daytona Beach, Florida

Conditions: Obesity, Weight Loss
Interventions: 1170-1870 kcal/day liquid diet, Gastric bypass surgery, Biopsy.visceral adipose tissue, Biopsy.omental adipose tissue, Biopsy. subcutaneous abdominal adipose tissue, Blood sample; Behavioral · Procedure
Lead sponsor: Boston Medical Center; Other
Eligibility: 18 Years to 65 Years
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2008
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Obesity & Overweight, Sarcopenia
Interventions: High Protein Diet Counceling, Standard Protein Diet Counceling, Protein Supplement, Supervised Exercise; Behavioral
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 50 Years to 75 Years
Enrollment: 250 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2031
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Overweight, Obesity
Interventions: pramlintide acetate, sibutramine, phentermine, placebo; Drug
Lead sponsor: AstraZeneca; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 258 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2007
U.S. locations: 16
States / cities: Birmingham, Alabama • Phoenix, Arizona • Chula Vista, California + 13 more

Conditions: Obesity, Weight Loss
Interventions: Weight loss without pharmacotherapy; Other
Lead sponsor: University of Colorado, Boulder; Other
Eligibility: 40 Years and older
Enrollment: 84 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Boulder, Colorado

Conditions: Obesity, Energy Balance, Appetite, Metabolism, Insulin Sensitivity
Interventions: Aerobic exercise, Newsletter; Behavioral
Lead sponsor: Children's Mercy Hospital Kansas City; Other
Eligibility: 14 Years to 17 Years
Enrollment: 31 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Kansas City, Missouri

Conditions: Pain, Postoperative
Interventions: Transdermal Lidocaine Patch, Transdermal Hydrocolloid Placebo Patch; Drug
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 18 Years to 59 Years · Female only
Enrollment: 66 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019
U.S. locations: 1
States / cities: Madison, Wisconsin

Search by objective public record fields.

Connected Health Care in Exercise Program for Obesity

Whey Protein Intake With and Without Exercise on Visceral Fat: The P+RISE Study

Low Dose Growth Hormone in Obese PCOS Women

Amlexanox for Type 2 Diabetes and Obesity

Mediterranean Diet, Weight Loss, and Cognition in Obese Older Adults

ENDObesity® II Study: TransPyloric Shuttle® System for Weight Loss

The HIIT Cognition Study

24-week Study Comparing Lixisenatide to Sitagliptin as add-on to Metformin in Obese Type 2 Diabetic Patients Younger Than 50 Years

Healthy Kids Beyond the Bell: Investigating the Impact of After-School and Summer Programs

Improving Reproductive Fitness Through Pretreatment With Lifestyle Modification in Obese Women With Unexplained Infertility

Safety and Efficacy of the SMART Device for Overweight and Obese Adults

Evaluation of Intra-Abdominal Fat in Patients With Type 2 Diabetes Using a Non-Invasive Method

Increased Cefazolin During Cesarean Delivery in Obese Population

Rivaroxaban Effects in Subjects Who Have Undergone Gastric Bypass Surgery

Gastric Plication and Banding

A Bilingual Virtually-based Intervention (PEDALL) for the Prevention of Weight Gain in Childhood ALL Patients Considering Key Genetic and Sociodemographic Risk Factors

Deep Brain Stimulation for the Treatment of Obesity

The Effect of AMG 133 on Gastric Emptying

Use of MCT Oil for Enhancement of Weight Loss in Obese Patients

Optimizing Adaptive Intensive Behavioral Therapy for Obesity During the Transition to Older Adulthood

A Study to Examine the Safety, Tolerability, and Body Weight Effect of Pramlintide Alone and in Combination With Oral Antiobesity Agents in Overweight and Obese Subjects

Adipocyte-Derived Extracellular Vesicles, Weight Loss, and Endothelial Function

Activity, Adiposity, and Appetite in Adolescents 2 Intervention

The OBstetric Lidocaine Patch (OBLido) Trial